69 related articles for article (PubMed ID: 9548508)
21. HepG2 human hepatoma cells express multiple cytokine genes.
Stonāns I; Stonāne E; Russwurm S; Deigner HP; Böhm KJ; Wiederhold M; Jäger L; Reinhart K
Cytokine; 1999 Feb; 11(2):151-6. PubMed ID: 10089137
[TBL] [Abstract][Full Text] [Related]
22. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
[TBL] [Abstract][Full Text] [Related]
23. Establishment of SSEA-1- and Oct-4-expressing rat embryonic stem-like cell lines and effects of cytokines of the IL-6 family on clonal growth.
Vassilieva S; Guan K; Pich U; Wobus AM
Exp Cell Res; 2000 Aug; 258(2):361-73. PubMed ID: 10896787
[TBL] [Abstract][Full Text] [Related]
24. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity.
Borsellino N; Bonavida B; Ciliberto G; Toniatti C; Travali S; D'Alessandro N
Cancer; 1999 Jan; 85(1):134-44. PubMed ID: 9921985
[TBL] [Abstract][Full Text] [Related]
25. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage.
Sui Y; Lee JH; DiMicco MA; Vanderploeg EJ; Blake SM; Hung HH; Plaas AH; James IE; Song XY; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2009 Oct; 60(10):2985-96. PubMed ID: 19790045
[TBL] [Abstract][Full Text] [Related]
26. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
[TBL] [Abstract][Full Text] [Related]
27. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced.
Galicia JC; Tai H; Komatsu Y; Shimada Y; Akazawa K; Yoshie H
Genes Immun; 2004 Sep; 5(6):513-6. PubMed ID: 15306846
[TBL] [Abstract][Full Text] [Related]
29. IL-6 transsignaling: the in vivo consequences.
Jones SA; Richards PJ; Scheller J; Rose-John S
J Interferon Cytokine Res; 2005 May; 25(5):241-53. PubMed ID: 15871661
[TBL] [Abstract][Full Text] [Related]
30. Effect of ciprofibrate on fibrinogen synthesis in vitro on hepatoma cells and in vivo in genetically obese Zucker rats.
Herbert JM; Bernat A; Chatenet-Duchène L
Blood Coagul Fibrinolysis; 1999 Jul; 10(5):239-44. PubMed ID: 10456614
[TBL] [Abstract][Full Text] [Related]
31. Characterization and biologic activities of recombinant rat soluble interleukin-6 receptor.
Thibault V; Terlain B; Gauldie J
J Interferon Cytokine Res; 1996 Nov; 16(11):973-81. PubMed ID: 8938575
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone enhances expression of membrane and soluble interleukin-6 receptors by prostate carcinoma cell lines.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1998; 18(6A):4403-8. PubMed ID: 9891500
[TBL] [Abstract][Full Text] [Related]
33. Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils.
Jablonska E; Marcinczyk M
Mediators Inflamm; 2003 Jun; 12(3):179-83. PubMed ID: 12857602
[TBL] [Abstract][Full Text] [Related]
34. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
35. Generation of 'truncated' interleukin-6 receptor (IL-6R) mRNA by alternative splicing; a possible source of soluble IL-6R.
Holub MC; Szalai C; Polgár A; Tóth S; Falus A
Immunol Lett; 1999 May; 68(1):121-4. PubMed ID: 10397166
[TBL] [Abstract][Full Text] [Related]
36. Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
Hasegawa M; Sato S; Ihn H; Takehara K
Rheumatology (Oxford); 1999 Jul; 38(7):612-7. PubMed ID: 10461473
[TBL] [Abstract][Full Text] [Related]
37. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes.
Kordula T; Rydel RE; Brigham EF; Horn F; Heinrich PC; Travis J
J Biol Chem; 1998 Feb; 273(7):4112-8. PubMed ID: 9461605
[TBL] [Abstract][Full Text] [Related]
38. C-reactive protein: a physiological activator of interleukin 6 receptor shedding.
Jones SA; Novick D; Horiuchi S; Yamamoto N; Szalai AJ; Fuller GM
J Exp Med; 1999 Feb; 189(3):599-604. PubMed ID: 9927522
[TBL] [Abstract][Full Text] [Related]
39. Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor.
Vollmer P; Peters M; Ehlers M; Yagame H; Matsuba T; Kondo M; Yasukawa K; Büschenfelde KH; Rose-John S
J Immunol Methods; 1996 Nov; 199(1):47-54. PubMed ID: 8960097
[TBL] [Abstract][Full Text] [Related]
40. Release of the soluble interleukin-6 receptor from human T-cells.
Banning U; Bönig H; Pafferath B; Klein-Vehne A; Burdach S; Körholz D
Immunol Invest; 1998; 27(1-2):47-55. PubMed ID: 9561917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
